Knoll Synthroid rebate program offered to purchasers selling 1 mil. tablets per quarter.
KNOLL SYNTHROID REBATES FOR DISPENSING MORE THAN 1 MIL. TABS per quarter are being offered through Knoll's "Retail Pharmacy Program," according to a December letter describing the program to pharmacies. The program, started in October, "provides the opportunity to earn payments for dispensing Synthroid (levothyroxine) when prescribed for members of eligible health plans and cash-paying customers not reimbursed by any plan," the letter states. "Payments include components for maintaining and for increasing Synthroid's percentage share of such prescriptions."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth